SHKK(SH:600272)2025-04-29 09:40Financial Performance - The company's operating revenue for Q1 2025 was CNY 269,631,863.97, representing a 15.05% increase compared to CNY 234,368,620.36 in the same period last year[3] - Net profit attributable to shareholders decreased by 65.70% to CNY 7,978,415.00 from CNY 23,260,067.14 year-on-year[3] - The net profit after deducting non-recurring gains and losses increased by 527.72% to CNY 1,475,028.43, driven by improved profitability in the regional medical consumables supply chain management business[3] - Basic and diluted earnings per share decreased by 65.63% to CNY 0.033 from CNY 0.096 in the same period last year[3] - Net profit for Q1 2025 was ¥11,483,451.33, a decrease of 50.54% from ¥23,180,215.70 in Q1 2024[13] - Earnings per share for Q1 2025 were ¥0.033, down from ¥0.096 in Q1 2024, indicating a decline of 65.63%[13] Cash Flow - The net cash flow from operating activities was CNY 83,376,437.31, a significant recovery from a negative cash flow of CNY -69,896,785.46 in the previous year[3] - In Q1 2025, the company reported cash inflows from operating activities of ¥335,206,036.09, a significant increase of 81.7% compared to ¥184,426,325.68 in Q1 2024[14] - The total cash inflow from operating activities was significantly higher than the cash outflow, indicating improved operational efficiency[14] Assets and Liabilities - Total assets increased by 3.63% to CNY 1,538,718,377.40 compared to CNY 1,484,859,580.95 at the end of the previous year[4] - The company's total liabilities as of March 31, 2025, amounted to ¥878,242,994.91, an increase from ¥835,867,649.79 as of December 31, 2024[11] - Current liabilities totaled ¥698,752,962.56 as of March 31, 2025, compared to ¥652,472,832.14 at the end of 2024, reflecting a growth of 7.09%[11] - The company's total equity increased to ¥660,475,382.49 as of March 31, 2025, from ¥648,991,931.16 at the end of 2024[11] Cash and Cash Equivalents - Cash and cash equivalents increased by 74.51%, attributed to a rise in the collection of accounts receivable[6] - The company's cash and cash equivalents at the end of Q1 2025 amounted to ¥183,246,558.16, an increase from ¥124,653,554.01 at the end of Q1 2024[14] Government Subsidies and Other Income - Other income increased by 68.15% due to higher government subsidies received compared to the previous year[6] - The company received government subsidies totaling RMB 4,591,000, including RMB 4,255,200 from its controlling shareholder for revitalization and rental support[9] Shareholder Information - The company reported a total of 39,977 common shareholders at the end of the reporting period[8] - The largest shareholder, Shanghai Kaikai (Group) Co., Ltd., holds 26.51% of the shares, totaling 64,409,783 shares[8] Inventory and Investments - Inventory increased to RMB 79,736,842.37 from RMB 78,191,971.80, showing a growth of about 1.98%[10] - Long-term equity investments decreased to RMB 101,912,498.81 from RMB 102,787,318.64, reflecting a decline of approximately 0.85%[10] Financial Expenses - The company’s financial expenses for Q1 2025 were ¥877,854.29, compared to a gain of ¥278,389.78 in Q1 2024, indicating a shift in financial performance[13] Accounting Standards - The company did not apply new accounting standards for the year 2025, maintaining consistency in financial reporting[15]